Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia

Journal of Urban Health

Volumn 90, Issue 1, 2013, Pages 157-166

  Magnus, Manya ^a   Kuo, Irene ^a   Phillips II, Gregory ^a   Rawls, Anthony ^a   Peterson, James ^a   Montanez, Luz ^a   West Ojo, Tiffany ^b   Jia, Yujiang ^b   Opoku, Jenevieve ^b   Kamanu Elias, Nnemdi ^b   Hamilton, Flora ^c   Wood, Angela ^c   Greenberg, Alan E ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b STD and Tuberculosis Administration   (United States)

^c Family and Medical Counseling Service   (United States)

Author keywords

Behavioral surveillance; Gender; HIV AIDS; HIV AIDS prevention; IDU

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DOMESTIC VIOLENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DISTRICT OF COLUMBIA; DOMESTIC VIOLENCE; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877619787     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9687-5     Document Type: Article

References (51)

1. DC Department of Health HIV/AIDS, Hepatitis, STD, and TB Administration. District of Columbia HIV/AIDS, Hepatitis, STD, and TB Epidemiology 2009 Annual Report Update, 2010.
2. Vlahov D, Des Jarlais DC, Goosby E, et al. The role of epidemiology in needle exchange programs. Am J Public Health. 2000; 90(9): 1390-2.
3. Holtzman D, Barry V, Ouellet LJ, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med. 2009; 49(1): 68-73.
4. Vlahov D, Des Jarlais DC, Goosby E, et al. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol. 2001; 154(12 Suppl): S70-7.
5. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 16(5): 400-6.
6. Absalon J, Fuller CM, Ompad DC, et al. Gender differences in sexual behaviors, sexual partnerships, and HIV among drug users in New York City. AIDS Behav. 2006; 10(6): 707-15.
7. Riehman KS, Kral AH, Anderson R, Flynn N, Bluthenthal RN. Sexual relationships, secondary syringe exchange, and gender differences in HIV risk among drug injectors. J Urban Health. 2004; 81(2): 249-59.
8. Garcia de la Hera M, Ferreros I, del Amo J, et al. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health. 2004; 58(11): 944-50.
9. Spijkerman IJ, Langendam MW, van Ameijden EJ, Coutinho RA, van den Hoek A. Gender differences in clinical manifestations before AIDS diagnosis among injecting drug users. Eur J Epidemiol. 1998; 14(3): 213-8.
10. Gollub EL, Rey D, Obadia Y, Moatti JP. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis. 1998; 25(9): 483-8.
11. Singh BK, Koman JJ 3rd, Williams JS, Catan VM, Souply KL. Sex differences in self-report of physical health by injection drug users. Int J Addict. 1994; 29(2): 275-83.
12. McDonald C, Loxley W, Marsh A. A bridge too near? Injecting drug users' sexual behaviour. AIDS Care. 1994; 6(3): 317-26.
13. Dwyer R, Richardson D, Ross MW, Wodak A, Miller ME, Gold J. A comparison of HIV risk between women and men who inject drugs. AIDS Educ Prev. 1994; 6(5): 379-89.
14. Montgomery SB, Hyde J, De Rosa CJ, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002; 28(3): 453-75.
15. Doherty MC, Garfein RS, Monterroso E, Latkin C, Vlahov D. Gender differences in the initiation of injection drug use among young adults. J Urban Health. 2000; 77(3): 396-414.
16. Latkin CA, Mandell W, Knowlton AR, et al. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev. 1998; 10(3): 257-63.
17. Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003; 80(1): 137-46.
18. Frears D. House passes bill that lifts ban on using federal money for needle exchanges. Washington Post 2009.
19. Pershing B. Spending bill spares D.C. needle exchange, Chesapeake cleanup plan. Washington Post 2011.
20. Opinion EB. Bargaining away the District's rights. Washington Post 2011.
21. Dvorak P. End of needle exchange marks loss of a bulwark in D.C.'s AIDS fight. Washington Post 2011;2/24/11.
22. Magnus M, Kuo I, Phillips G 2nd, et al. Elevated HIV prevalence despite lower rates of sexual risk behaviors among black men in the District of Columbia who have sex with men. AIDS Patient Care STDS. 2010; 24(10): 615-22.
23. Magnus M, Kuo I, Shelley K, et al. Risk factors driving the emergence of a generalized heterosexual HIV epidemic in Washington, District of Columbia networks at risk. Aids. 2009; 23(10): 1277-84.
24. Kuo I, Greenberg AE, Magnus M, et al. High prevalence of substance use among heterosexuals living in communities with high rates of AIDS and poverty in Washington, DC. Drug Alcohol Depend. 2011;117:139-44.
25. Abdul-Quader AS, Heckathorn DD, McKnight C, et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health. 2006; 83(3): 459-76.
26. Abdul-Quader AS, Heckathorn DD, Sabin K, Saidel T. Implementation and analysis of respondent driven sampling: lessons learned from the field. J Urban Health. 2006; 83(6 Suppl): i1-5.
27. Abdul-Quader AS, Heckathorn DD, Sabin K, Saidel T, Ramirez-Valles J, Heckathorn DD, Vázquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005; 9(4): 387-402.
28. Deiss RG, Brouwer KC, Loza O, Lozada RM, Ramos R, FirestoneCruz MA, Patterson TL, Heckathorn DD, Frost SD, Strathdee SA. High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex Transm Dis. 2008; 35: 243-249.
29. Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems. 1997; 44(2): 174-99.
30. Heckathorn D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Social Problems. 2002; 49(1): 11-34.
31. Heckathorn D. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociological Methodology 2007;37:151-207.
32. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. Aids. 2005; 19(Suppl 2): S67-72.
33. McKnight C, Des Jarlais D, Bramson H, et al. Respondent-driven sampling in a study of drug users in New York City: notes from the field. J Urban Health. 2006; 83(6 Suppl): i54-9.
34. Ramirez-Valles J, Heckathorn DD, Vazquez R, Diaz RM, Campbell RT. From networks to populations: the development and application of respondent-driven sampling among IDUs and Latino gay men. AIDS Behav. 2005; 9(4): 387-402.
35. Semaan S, Santibanez S, Garfein RS, Heckathorn DD, Des Jarlais DC. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. Int J Drug Policy 2008. Am J Public Health. 2010;100:582-3.
36. Stormer A, Tun W, Guli L, et al. An analysis of respondent driven sampling with Injection Drug Users (IDU) in Albania and the Russian Federation. J Urban Health. 2006; 83(6 Suppl): i73-82.
37. Lansky A, Drake A, DiNenno E, Lee CW. HIV behavioral surveillance among the U.S. general population. Public Health Rep. 2007; 122(Suppl 1): 24-31.
38. Woods WJ, Lindan CP, Hudes ES, Boscarino JA, Clark WW, Avins AL. HIV infection and risk behaviors in two cross-sectional surveys of heterosexuals in alcoholism treatment. J Stud Alcohol. 2000; 61(2): 262-6.
39. Unger JB, Kipke MD, De Rosa CJ, Hyde J, Ritt-Olson A, Montgomery S. Needle-sharing among young IV drug users and their social network members: the influence of the injection partner's characteristics on HIV risk behavior. Addict Behav. 2006; 31(9): 1607-18.
40. Bennett GA, Velleman RD, Barter G, Bradbury C. Gender differences in sharing injecting equipment by drug users in England. AIDS Care. 2000; 12(1): 77-87.
41. Wisniewski AB, Apel S, Selnes OA, Nath A, McArthur JC, Dobs AS. Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol. 2005; 11(2): 138-43.
42. Cruz MF, Mantsios A, Ramos R, et al. A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behav. 2007; 11(2): 253-62.
43. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001; 161(10): 1281-8.
44. Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse. 1999; 25(1): 117-27.
45. Latkin CA, Mandell W. Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. Int J Addict. 1993; 28(14): 1601-12.
46. Purcell DW, Mizuno Y, Metsch LR, et al. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: associations by partner type and partner serostatus. J Urban Health. 2006; 83(4): 656-68.
47. Burt RD, Hagan H, Sabin K, Thiede H. Evaluating respondent-driven sampling in a major metropolitan area: comparing injection drug users in the 2005 Seattle area national HIV behavioral surveillance system survey with participants in the RAVEN and Kiwi studies. Ann Epidemiol. 2005; 20(2): 159-67.
48. Abramovitz D, Volz EM, Strathdee SA, Patterson TL, Vera A, Frost SD. Using respondent-driven sampling in a hidden population at risk of HIV infection: who do HIV-positive recruiters recruit? Sex Transm Dis. 2009; 36(12): 750-6.
49. Lansky A, Abdul-Quader AS, Cribbin M, et al. Developing an HIV behavioral surveillance system for injecting drug users: the National HIV Behavioral Surveillance System. Public Health Rep. 2007; 122(Suppl 1): 48-55.
50. Platt L, Wall M, Rhodes T, et al. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health. 2006; 83(6 Suppl): i39-53.
51. Robinson WT, Risser JM, McGoy S, et al. Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. J Urban Health. 2006; 83(6 Suppl): i29-38.